A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma

Lung Cancer

Volumn 83, Issue 2, 2014, Pages 240-245

  Cao, Christopher ^a,b,c   Tian, David ^a   Park, John ^a   Allan, James ^a   Pataky, Kristopher A ^a   Yan, Tristan D ^a,d  

^a MACQUARIE UNIVERSITY   (Australia)

^b ST GEORGE HOSPITAL   (Australia)

^c Baird Institute for Applied Heart and Lung Surgical Research   (Australia)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Mesothelioma; Meta analysis; Pleurectomy; Pneumonectomy; Surgery; Systematic review

Indexed keywords

ARTICLE; CANCER SURGERY; CANCER SURVIVAL; DECORTICATION; EXTENDED PLEURECTOMY; EXTRAPLEURAL PNEUMONECTOMY; HUMAN; LONG TERM SURVIVAL; LUNG RESECTION; META ANALYSIS; MORBIDITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SELECTION; PERIOPERATIVE PERIOD; PLEURA MESOTHELIOMA; PLEURECTOMY; PRIORITY JOURNAL; SURGICAL MORTALITY; SYSTEMATIC REVIEW;

MESOTHELIOMA; META-ANALYSIS; PLEURECTOMY; PNEUMONECTOMY; SURGERY; SYSTEMATIC REVIEW;

CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; MESOTHELIOMA; PERIOPERATIVE PERIOD; PLEURA; PLEURAL NEOPLASMS; PNEUMONECTOMY; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84892848039     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2013.11.026     Document Type: Article

References (29)

1. Robinson B. Malignant pleural mesothelioma: an epidemiological perspective. Ann Cardiothorac Surg 2012, 1:491-496.
2. Rusch V.W. A phase II study of intrapleural immunochemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy, and long-term subcutaneous IL-2 in stage II-III malignant pleural mesothelioma. Eur J Cardiothorac Surg 2007, 31:534-535.
3. Zellos L., Richards W.G., Capalbo L., Jaklitsch M.T., Chirieac L.R., Johnson B.E., et al. A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2009, 137:453-458.
4. Wolf A.S., Daniel J., Sugarbaker D.J. Surgical techniques for multimodality treatment of malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy/decortication. Semin Thorac Cardiovasc Surg 2009, 21:132-148.
5. Rusch V.W. Extrapleural pneumonectomy and extended pleurectomy/decortication for malignant pleural mesothelioma: the Memorial Sloan-Kettering Cancer Center approach. Ann Cardiothorac Surg 2012, 1:523-531.
6. Cao C., Tian D.H., Pataky K.A., Yan T.D. Systematic review of pleurectomy in the treatment of malignant pleural mesothelioma. Lung Cancer 2013.
7. Cao C.Q., Yan T.D., Bannon P.G., McCaughan B.C. A systematic review of extrapleural pneumonectomy for malignant pleural mesothelioma. J Thorac Oncol 2010, 5:1692-1703.
8. Treasure T., Waller D., Tan C., Entwisle J., Obrien M., Obyrne K., et al. The mesothelioma and radical surgery randomized controlled trial: The MARS feasibility study. J Thorac Oncol 2009, 4:1254-1258.
9. Treasure T. Surgery for mesothelioma: MARS landing and future missions. Eur J Cardiothorac Surg 2010, 37(3):509-510.
10. Treasure T., Mesothelioma Utley M. Benefit from surgical resection is questionable. Journal of Thoracic Oncology 2007, 2:885-886.
11. Rice D., Rusch V., Pass H., Asamura H., Nakano T., Edwards J., et al. International Association for the Study of Lung Cancer International Staging C, the International Mesothelioma Interest G. Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: a consensus report of the international association for the study of lung cancer international staging committee and the international mesothelioma interest group. J Thoracic Oncol: Official Publication of the International Association for the Study of Lung Cancer 2011, 6:1304-1312.
12. Cao C., Tian D., Manganas C., Matthews P., Yan T.D. Systematic review of trimodality therapy for patients with malignant pleural mesothelioma. Ann Cardiothorac Surg 2012, 1:428-437.
13. Van Schil P.E., Baas P., Gaafar R., Maat A.P., Van de Pol M., Hasan B., et al. Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial. Eur Respir J 2010, 36:1362-1369.
14. Krug L.M., Pass H.I., Rusch V.W., Kindler H.L., Sugarbaker D.J., Rosenzweig K.E., et al. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol 2009, 27:3007-3013.
15. Rea F., Marulli G., Bortolotti L., Breda C., Favaretto A.G., Loreggian L., et al. Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): Feasibility and results. Lung Cancer 2007, 57:89-95.
16. Weder W., Stahel R.A., Bernhard J., Bodis S., Vogt P., Ballabeni P., et al. Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol 2007, 18:1196-1202.
17. Demmy T. Video-assisted thoracoscopic extrapleural pneumonectomy for malignant pleural mesothelioma. Ann Cardiothorac Surg 2012, 1:533.
18. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
19. Bedirhan M.A., Cansever L., Demir A., Ceyhan S., Akn H., Urer H.N., et al. Which type of surgery should become the preferred procedure for malignant pleural mesothelioma: extrapleural pneumonectomy or extended pleurectomy. J Thorac Dis 2013, 5:446-454.
20. Lang-Lazdunski L., Bille A., Lal R., Cane P., McLean E., Landau D., et al. Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma. J Thorac Oncol 2012, 7:737-743.
21. Nakas A., von Meyenfeldt E., Lau K., Muller S., Waller D. Long-term survival after lung-sparing total pleurectomy for locally advanced (International Mesothelioma Interest Group Stage T3-T4) non-sarcomatoid malignant pleural mesothelioma. Eur J Cardiothorac Surg 2012, 41:1031-1036.
22. Rena O., Casadio C. Extrapleural pneumonectomy for early stage malignant pleural mesothelioma: a harmful procedure. Lung Cancer 2012, 77:151-155.
23. Flores R.M., Pass H.I., Seshan V.E., Dycoco J., Zakowski M., Carbone M., et al. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: Results in 663 patients. J Thorac Cardiovasc Surg 2008, 135:620-626. e623.
24. Okada M., Mimura T., Ohbayashi C., Sakuma T., Soejima T., Tsubota N. Institutional report - Thoracic general. Radical surgery for malignant pleural mesothelioma: Results and prognosis. Interactive Cardiovasc. Thoracic Surg. 2008, 7:102-106.
25. Ploenes T., Osei-Agyemang T., Krohn A., Waller C.F., Duncker-Rohr V., Elze M., et al. Changes in lung function after surgery for mesothelioma. Asian Cardiovasc Thorac Ann 2013, 21:48-55.
26. Cao C., Yan T.D., Bannon P.G., McCaughan B.C. Summary of prognostic factors and patient selection for extrapleural pneumonectomy in the treatment of malignant pleural mesothelioma. Ann Surg Oncol 2011, 18:2973-2979.
27. Treasure T., Lang-Lazdunski L., Waller D., Bliss J.M., Tan C., Entwisle J., et al. Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol 2011, 12:763-772.
28. Weder W., Stahel R.A., Baas P., Dafni U., de Perrot M., McCaughan B.C., et al. The MARS feasibility trial: conclusions not supported by data. Lancet Oncol 2011, 12:1093-1094. author reply 1094-1095.
29. Rusch V.W. The Mars trial: resolution of the surgical controversies in mesothelioma. J Thorac Oncol: Official Publication of the International Association for the Study of Lung Cancer 2009, 4:1189-1191.